mazdaki

CERS on Sell after the earnings call.

Long
NASDAQ:CERS   Cerus Corporation
1
I don't think the analyst have come to grasp the potential of this stock yet!. I have knowledge of the field and the FDA approvals should improve sales. Technically, we are still in the wedge and I think we will breakout of the wedge in the up side as opposed to the down so I will continue to accumulate as much as possible for the long term.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.